Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve 1) To consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 31st December, 2025.\r\n\r\n2) To consider and approve the Limited Review Report (Standalone & Consolidated) for the quarter ended 31st December, 2025.\r\n\r\n3) To transact such other business as may be required.\r\n\r\n\r\n